Detailed Information
Cited 0 time in 
Cited 16 time in 
Cited 16 time in
Metadata Downloads
In vivo and in vitro anticancer activity of doxorubicin-loaded DNA-AuNP nanocarrier for the ovarian cancer treatmentopen access
- Authors
- Lee, Chang-Seuk; Kim, Tae Wan; Oh, Da Eun; Bae, Su Ok; Ryu, Jaesung; Kong, Hyejeong; Jeon, Hyeji; Seo, Hee Kyung; Jeon, Seob; Kim, Tae Hyun
- Issue Date
- Mar-2020
- Publisher
- Multidisciplinary Digital Publishing Institute (MDPI)
- Keywords
- Nanomedicine; doxorubicin; gold nanoparticles; ovarian cancer; drug delivery
- Citation
- Cancers, v.12, no.3
- Journal Title
- Cancers
- Volume
- 12
- Number
- 3
- ISSN
- 2072-6694
- Abstract
- In this study, we have determined the anticancer activity of doxorubicin (Dox)-loaded DNA/gold nanoparticle (AuNP) nanocarrier (Dox-DNA-AuNP) for the treatment of ovarian cancer. The anticancer effect of Dox-DNA-AuNP was evaluated in vitro using the EZ-Cytox cell viability assay on three human ovarian cancer cell lines, SK-OV-3, HEY A8, and A2780. Dox-DNA-AuNP exhibited outstanding activity with good IC50 values of 4.8, 7.4, and 7.6 nM for SK-OV-3, HEY A8, and A2780, respectively. In vivo evaluation further demonstrated the superior anticancer effects of Dox-DNA-AuNP by inhibiting tumor growth compared to free Dox in an established SK-OV-3 xenograft mice model. Dox-DNA-AuNP showed about a 2.5 times higher tumor growth inhibition rate than free Dox. Furthermore, the immunohistochemical analysis of Ki67 antigen expression showed the lowest number of proliferative cells in the ovarian tumor tissue treated with Dox-DNA-AuNP. These results suggest Dox-DNA-AuNP might be a potential effective agent in ovarian cancer chemotherapy.
- Files in This Item
- There are no files associated with this item.
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Related Researcher
- Kim, Tae Hyun
- College of Natural Sciences (Department of Chemistry)